About Implicity
Implicity is a pioneer in SaaS agnostic platforms for cardiac implantable electronic device (CIED) remote monitoring, equipped with FDA-cleared AI-driven software as a medical device. The company's platform centralizes and standardizes all cardiac device data into one unified system, enabling healthcare providers to monitor patients more efficiently and make faster, more confident clinical decisions. The platform features AI-driven alert management that filters false positives, smart workflow automation for billing and reporting, and real-time access from anywhere. Implicity serves physicians, care teams, administrative staff, and IT teams across cardiology practices and health systems. The platform has demonstrated significant clinical impact, with studies showing a 26% reduction in mortality and 4% reduction in hospitalization length compared to conventional remote monitoring. Key product features include the ILR ECG Analyzer that reduces false positives by 79%, AF Alert Management that decreases unnecessary atrial fibrillation alerts by 85%, Patient Connectivity Management that reconnects 28% of disconnected patients within two days, and SignalHF predictive AI for heart failure hospitalization prediction. The company holds multiple FDA clearances and CE marks for its medical device software, and maintains certifications including HIPAA and SOC2 compliance. Implicity serves healthcare providers across the United States and Europe, with separate platforms for each region.
Clinical Focus
Medical conditions and clinical areas addressed by Implicity.
Who It Serves
Milestones & Awards
Recent Milestones
Selected as official remote monitoring platform for DAI-PP2, one of the largest European research consortiums on ICDs with 5,000+ patients expected enrollment. Multiple customer implementations including Virginia Cardiovascular Consultants, Citizens Medical Center's Cardiovascular Associates of Victoria, and Cardio Vascular Health Clinic.
Awards & Recognition
Selected as official remote monitoring platform for DAI-PP, one of the largest European research consortiums on ICDs
Key Partnerships
Social & Media
Latest Updates
Management of CIEDs with New Remote Monitoring Features: from Standard of Care to AI
Interview with Dr. Arnaud Rosier, CEO of Implicity
Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices
Video Library
Q&A around AI in healthcare with HTID
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biobeat
Biobeat develops FDA-cleared cuffless ambulatory blood pressure monitoring (ABPM) solutions using a wireless, non-invasive chest patch. The company enables 24-hour hypertension monitoring for cardiologists, nephrologists, and hypertension centers to improve diagnosis accuracy and treatment management.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.